e-2200 (Cannabis)
Original language of petition: English
Petition to the House of Commons
- In 2018, the Federal Cannabis Act was created, classifying all phytocannabinoids as Schedule 1 substances under this Act, including Cannabidiol (CBD), derived from either Cannabis or Industrial Hemp plants;
- The current Industrial Hemp Regulations impose limitations to processing the whole hemp plant, allowing derivatives only to be extracted from the hemp seed, restricting CBD extracted from hemp;
- CBD is non-psychoactive and was addressed by the World Health Organization which stated that CBD exhibits no effects indicative of any abuse or dependence potential; and
- CBD is currently being used by Canadians, non-recreationally, to help with symptoms of disorders such as: anxiety/mood, chronic pain/inflammation, seizures, and other conditions.
- Open for signature
- May 22, 2019, at 2:56 p.m. (EDT)
- Closed for signature
- July 21, 2019, at 2:56 p.m. (EDT)